Overview of Aldawaa financial performance in H1 2023
Logo of Aldawaa Medical Services Co.
Aldawaa Medical Services Co. reported a 47% rise year-on-year (YoY) in operating income to SAR 237 million in the first half of 2023, driven primarily by sales growth and controlled selling and distribution expenses.
The company’s sales grew nearly 9% YoY to SAR 2.84 billion in the six-month period, thanks to increased seasonal sales activities, strong campaigns, and effective multi-channel operations, according to the company.
Gross profit increased 6% YoY to SAR 1.06 billion, on sales growth. By contrast, operating expenses (OpEx) declined to SAR 823.6 million in H1 2023, from SAR 839.7 million in the prior-year period.
Sales & Operating Income (SAR mln) - Interim |
|||
Item |
H1 2022 |
H1 2023 |
Change % |
Sales |
2605.0 |
2844.3 |
+9% |
Gross Profit |
1001.0 |
1060.6 |
+6% |
OpEx |
(839.7) |
(823.6) |
(2%) |
Operating Income |
161.3 |
237.0 |
+47% |
On a quarterly basis, operating income reached SAR 122 million, registering a rise of 35% YoY, backed by better sales and lower OpEx.
Aldawaa’s sales rose around 10% YoY to SAR 1.43 billion in Q2 2023.
Gross profit increased 4% YoY to SAR 525.6 million. OpEx dropped to SAR 403.6 million in Q2 2023 from SAR 416.2 million in Q2 2022.
Sales & Operating Income (SAR mln) Quarterly |
|||||
Item |
2022 |
2023 |
|||
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
|
Sales |
1310.2 |
1308.9 |
1458.3 |
1407.6 |
1436.7 |
Gross Profit |
506.8 |
484.9 |
533.7 |
535.0 |
525.6 |
OpEx |
(416.2) |
(402.3) |
(408.6) |
(420.0) |
(403.6) |
Operating Income |
90.6 |
82.7 |
125.1 |
115.0 |
122.0 |
Aldawaa’s financial results showed that the second quarter of 2022 included SAR 14.5 million in non-recurring, one-off profits from derivative swap contracts. This, in turn, pushed profit higher to SAR 80.7 million in Q2 2022.
The company’s Q2 2023 net profit jumped 35% YoY, excluding derivatives profits, to SAR 89.3 million.
Sales & Operating Income (SAR mln) |
|||||
Item |
2022 |
2023 |
|||
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
|
Net Profit Excluding Derivative Swap Contracts |
66.2 |
49.2 |
89.6 |
76.3 |
89.3 |
Derivative Swap Profit |
14.5 |
(1.1) |
(0.04) |
-- |
-- |
Net Profit after Derivatives |
80.7 |
48.2 |
89.5 |
76.3 |
89.3 |
- UCIC sets TASI IPO price range at SAR 47-50/share
- Abdullah Al Rajhi: alrajhi bank's profits increased to SAR 5,906 million in the first quarter of 2025, while total assets exceeded SAR 1 trillion
- Saudi economy forecast to grow 3% in 2025: IMF
- solutions signs SAR 142.4M contract with stc
- HPDC and BRF Break Ground on Major Halal Poultry Facility in Jeddah, Strengthening Saudi Arabia’s Position in the Global Halal Market
Market Indices
Quotes
Current | |
Market Cap (M Riyal) | 6,664.00 |
Shares Outstanding ((M)) | 85.00 |
EPS ( | ) (TTM)4.35 |
Book Value (BV) ( Riyal) (Latest announcement) | 17.13 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 18.01 |
Price/book | 4.58 |
Dividend Yield (%) (Last Year) | 3.19 |
Return on Average Assets (%) (TTM) | 7.60 |
Return on Average Equity (%) (TTM) | 26.73 |
Enterprise Value (EV) (M) | 7,235.10 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments
Be the first to comment